Mario Colucci - Concepedia

Author

Mario Colucci

Also Known As

Anna D’Aprile, Anna Pentimone, M Colucci, M. COLUCCI, M. Colucci, Maria Rosaria Rossiello, Mario Colucci, Mattia Colucci

205

Publications

5.9K

Citations

H-Index

159

Concepts

All Affiliations

University of Bari Aldo Moro Mario Negri Institute for Pharmacological Research KU Leuven University of Perugia University of Milan

About

Mario Colucci is an author at University of Bari Aldo Moro specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	57	3.6K
2	Health Sciences	11	11	1.1K
3	Public Health	4	4	203
4	Engineering	1	1	12
5	Natural Sciences	1	1	11

Mario Colucci

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Cultured human endothelial cells generate tissue factor in response to endotoxin. Mario Colucci, Giovanna Balconi, Roberto Lorenzet, Journal of Clinical Investigation ImmunologyEndotoxin EffectsCulture MediumCellular PhysiologyInflammation	1983	511
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. Mario Colucci, José A. Páramo, D Collen Journal of Clinical Investigation ImmunologyEscherichia ColiPharmacotherapyExperimental PharmacologyDrug Resistance	1985	399
THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTS Yves Vanrenterghem, L Roels, P. Michielsen, The Lancet UrologyTransplantationKidney TransplantMedicineKidney Transplantation	1985	328
Plasminogen activator inhibitor in the blood of patients with coronary artery disease. José A. Páramo, Mario Colucci, D Collen, BMJ	1985	306
Tissue Factor in Health and Disease N. Semeraro, Mario Colucci Thrombosis and Haemostasis ImmunologyPathologyInflammationThrombosisFibrin Deposition	1997	180
SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE N. Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mediterranean Journal of Hematology and Infectious Diseases InflammationThrombosisThrombopoiesisSevere SepsisBlood Platelet	2010	164
Deficiency of Thrombin Activatable Fibrinolysis Inhibitor in Cirrhosis Is Associated With Increased Plasma Fibrinolysis Mario Colucci, Bianca M. Binetti, Maria G. Branca, Hepatology Tafi DeficiencyVitro Plasma HyperfibrinolysisVitro FibrinolysisImmunologyPathology	2003	144
Effectiveness of Hepatitis B Vaccination in Babies Born to Hepatitis B Surface Antigen–Positive Mothers in Italy Alfonso Mele, Francesco Tancredi, Luisa Romanò, The Journal of Infectious Diseases ImmunologyHepatitis BVaccine HesitancyImmunotherapyMaternal Immunization	2001	117
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor Concetta T. Ammollo, Fabrizio Semeraro, Francesca Incampo, Journal of Thrombosis and Haemostasis ThrombosisMechanisms DependentThrombin‐activatable Fibrinolysis InhibitorMedicineHematology	2010	107
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. Paolo Gresele, Stefania Momi, Mauro Berrettini, Journal of Clinical Investigation ImmunologyPharmacotherapyThrombin-induced ThromboembolismInflammationThrombosis	1998	103

Page 1